Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,946,091
-
Share change
-
-64,470
-
Total reported value
-
$54,401,693
-
Price per share
-
$11.00
-
Number of holders
-
30
-
Value change
-
+$270,550
-
Number of buys
-
14
-
Number of sells
-
18
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q3 2017
As of 30 Sep 2017,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,946,091 shares.
The largest 10 holders included
Vivo Capital, LLC, INTERWEST VENTURE MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., PERCEPTIVE ADVISORS LLC, Boxer Capital, LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, DEUTSCHE BANK AG\, P.A.W. CAPITAL CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.